Gilead Sciences Inc. stock underperforms Thursday when compared to competitors
The stock's fall snapped a five-day winning streak.
Gilead to donate remdesivir for emergency use against Marburg disease in Rwanda
Gilead Sciences said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical ...
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...
BioSpace10h
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
GlobalData on MSN13h
Gilead signs agreements to facilitate access to HIV prevention drug
Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...
Ferozsons Partners With Gilead Sciences to Produce HIV Medicine in Pakistan
Ferozsons Laboratories Limited (PSX: FEROZ) has entered into a non-exclusive voluntary license agreement with Gilead Sciences ...
Zacks.com on MSN12h
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
bovnews6h
Gilead Sciences, Inc. (GILD) Stock Price Reaches $84.74: What Factors Are Influencing This Level?
On Wednesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.74 which represents a slight increase of $0.80 or 0.95% from the prior close of $83.94. The stock opened at ...
Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug Lenacapavir
Emcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for ...
pharmaphorum13h
Gilead strikes deal to expand HIV drug access in 120 countries
If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...
Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application
Six drugmakers sign agreements with Gilead Sciences to produce generic lenacapavir, a long-acting HIV drug, amid patent ...
Daily11h
Gilead Sciences inks pacts with Dr Reddy's Labs, Emcure, Hetero and 3 others for HIV drug Lenacapavir
Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...